JCM
IDXX icon

JS Capital Management’s Idexx Laboratories IDXX Stock Holding History

JS Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,500
Closed -$392K – 161
2019
Q4 		$392K Buy
+1,500
New +$395K 0.05% 89

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

JS Capital Management's IDXX Position: Q1 2020 in Review

JS Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 1,500 shares — an estimated $392K sold.

JS Capital Management first reported a position in IDXX in Q4 2019 and held it in 1 quarter. The position peaked at $392K in Q4 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • JS Capital Management reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • JS Capital Management sold 1,500 Idexx Laboratories shares in Q1 2020, an estimated $392K.
  • JS Capital Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 1 quarter.
  • JS Capital Management's Idexx Laboratories position peaked at $392K in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on JS Capital Management's 13F filing for Q1 2020, filed 15 May 2020.